ResearcherUniversity of ZurichActive in the last 2 years
Chantal Pauli
Matched on ORCID iD 0000-0001-9621-8511; OpenAlex author ID A5039120517. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 2 papers
Papers 5
- PI5P4Kα promotes glucose and iron acquisition to support metabolic fitness in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2025.116199↗
- A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in pancreatic cancer. Co-author DOI 10.1016/j.esmogo.2025.100134↗
- Ex vivo modeling of acquired drug resistance in BRAF - mutated pancreatic cancer organoids uncovers individual therapeutic vulnerabilities. Last author DOI 10.1016/j.canlet.2024.216650↗
- SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2022.111266↗
- Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment. Co-author DOI 10.1016/j.xgen.2022.100095↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daniela M. Lenggenhager · 4 shared papers, 2022–2025 · strength 0.66
- Paper A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in p… DOI 10.1016/j.esmogo.2025.100134↗
- Paper Ex vivo modeling of acquired drug resistance in BRAF - mutated pancreatic cancer organoids uncovers individual therapeu… DOI 10.1016/j.canlet.2024.216650↗
- Paper Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates… DOI 10.1016/j.xgen.2022.100095↗
- Saskia Hussung · 2 shared papers, 2024–2025 · strength 0.43
- Paper A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in p… DOI 10.1016/j.esmogo.2025.100134↗
- Paper Ex vivo modeling of acquired drug resistance in BRAF - mutated pancreatic cancer organoids uncovers individual therapeu… DOI 10.1016/j.canlet.2024.216650↗
- Ralph Fritsch · 2 shared papers, 2024–2025 · strength 0.43
- Paper A stratified two-stage tumor molecular profiling algorithm to identify clinically actionable molecular alterations in p… DOI 10.1016/j.esmogo.2025.100134↗
- Paper Ex vivo modeling of acquired drug resistance in BRAF - mutated pancreatic cancer organoids uncovers individual therapeu… DOI 10.1016/j.canlet.2024.216650↗
- Christian Hirt · 2 shared papers, 2022 · strength 0.22
- Patrik Simmler · 2 shared papers, 2022 · strength 0.22
- Gerald Schwank · 2 shared papers, 2022 · strength 0.22
- Sabrina Steiner · 1 shared paper, 2024 · strength 0.21
- Yoav Altman · 1 shared paper, 2025 · strength 0.20
- Cheska Marie Galapate · 1 shared paper, 2025 · strength 0.20
- Brooke M. Emerling · 1 shared paper, 2025 · strength 0.20
- Ling Li · 1 shared paper, 2025 · strength 0.20
- Gurpreet K. Arora · 1 shared paper, 2025 · strength 0.20
- Cosimo Commisso · 1 shared paper, 2025 · strength 0.20
- Hagen Klett · 1 shared paper, 2022 · strength 0.11
- Gunnar Rätsch · 1 shared paper, 2022 · strength 0.11
- Ilaria Guccini · 1 shared paper, 2022 · strength 0.11
- Markus Stoffel · 1 shared paper, 2022 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.